ES2013186A6 - Un procedimiento para preparar un derivado de fenilalcanoilamina. - Google Patents
Un procedimiento para preparar un derivado de fenilalcanoilamina.Info
- Publication number
- ES2013186A6 ES2013186A6 ES8901577A ES8901577A ES2013186A6 ES 2013186 A6 ES2013186 A6 ES 2013186A6 ES 8901577 A ES8901577 A ES 8901577A ES 8901577 A ES8901577 A ES 8901577A ES 2013186 A6 ES2013186 A6 ES 2013186A6
- Authority
- ES
- Spain
- Prior art keywords
- derivative
- preparing
- procedure
- disorders
- phenylalcanoylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
UN PROCEDIMIENTO PARA PREPARAR UN DERIVADO DE FENILALCANOILAMINA. COMPRENDE: HACER REACCIONAR UN ACIDO FENILALCANOICO O UN DERIVADO ACTIVO DEL MISMO DE FORMULA (II) CON 1,3-TIAZOLIDINA, 1,2,3,6-TETRAHIDROPIRIDINA, MORFOLINA, TIOMORFOLINA O 3-PIRROLINA PARA PRODUCIR EL COMPUESTO DE FORMULA (IK). EN LAS FORMULAS ANTERIORES, R1K, R2K Y AK REPRESENTAN DIFERENTES RADICALES ORGANICOS, N ES UN ENTERO DE 2 A 6 E Y REPRESENTA UN ATOMO DE HALOGENO, UN RESTO ESTER ACTIVO O UN GRUPO HIDROXI. ESTOS COMPUESTOS SON UTILES PARA TRATAR O PREVENIR TRASTORNOS DE LA CIRCULACION CEREBRAL, TRASTORNOS DEL METABOLISMO CEREBRAL O TRASTORNOS DE LA MEMORIA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11206788 | 1988-05-09 | ||
| JP1057865A JPH0262858A (ja) | 1988-05-09 | 1989-03-13 | 新規フェニルアルカノイルアミン誘導体、製法ならびに用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2013186A6 true ES2013186A6 (es) | 1990-04-16 |
Family
ID=26398957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES8901577A Expired - Lifetime ES2013186A6 (es) | 1988-05-09 | 1989-05-08 | Un procedimiento para preparar un derivado de fenilalcanoilamina. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5198450A (es) |
| EP (1) | EP0424528A4 (es) |
| JP (1) | JPH0262858A (es) |
| KR (1) | KR900701750A (es) |
| DK (1) | DK267890A (es) |
| ES (1) | ES2013186A6 (es) |
| WO (1) | WO1989010918A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1336388A (fr) * | 1961-08-04 | 1963-08-30 | Boehringer Sohn Ingelheim | Procédé pour la préparation des amides d'acides phénylalcoylcarboxyliques |
| FR2043467A1 (es) * | 1969-05-12 | 1971-02-19 | Clin Byla Ets | |
| DE2021445C3 (de) * | 1969-05-12 | 1975-12-11 | Clin Byla Ets | 4-Phenylbuttersäurederivate, ein Verfahren zu ihrer Herstellung und Arzneimittel |
| US4857524A (en) * | 1987-08-08 | 1989-08-15 | Kissei Pharmaceutical Co., Ltd. | Thiazolidine compounds and therapeutic method |
-
1989
- 1989-03-13 JP JP1057865A patent/JPH0262858A/ja active Pending
- 1989-05-01 WO PCT/JP1989/000461 patent/WO1989010918A1/ja not_active Ceased
- 1989-05-01 EP EP19890905187 patent/EP0424528A4/en not_active Ceased
- 1989-05-01 US US07/601,795 patent/US5198450A/en not_active Expired - Fee Related
- 1989-05-08 ES ES8901577A patent/ES2013186A6/es not_active Expired - Lifetime
-
1990
- 1990-01-04 KR KR1019900700011A patent/KR900701750A/ko not_active Ceased
- 1990-11-08 DK DK267890A patent/DK267890A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0262858A (ja) | 1990-03-02 |
| DK267890D0 (da) | 1990-11-08 |
| DK267890A (da) | 1991-01-02 |
| WO1989010918A1 (fr) | 1989-11-16 |
| EP0424528A4 (en) | 1992-02-05 |
| EP0424528A1 (en) | 1991-05-02 |
| US5198450A (en) | 1993-03-30 |
| KR900701750A (ko) | 1990-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2001019A6 (es) | Procedimiento para preparar hidroxialquilxantinas terciarias | |
| ES2073653T3 (es) | Derivados de adenosina 2-substituidos y composiciones farmaceuticas para las enfermedades del sistema circulatorio. | |
| ES2037208T3 (es) | Un metodo para preparar derivados 3-aminometilicos de indano, indolina, dihidrobenzofurano y dihidrobenzotiofeno. | |
| ATE106726T1 (de) | Angiogenese hemmendes mittel. | |
| UA27749C2 (uk) | Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
| TNSN87042A1 (fr) | Procede de preparation de nouveaux steroides comportant un cycle spirannique en position 17 | |
| NO870771D0 (no) | Fremgangsmaate ved fremstilling av nye, terapeutisk aktive 1,2,5,6-tetrahydropyridin-3-carboxaldehydoximderivater. | |
| DE3870801D1 (de) | Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten. | |
| ES2072263T3 (es) | Derivados de 4-aminopiridina. | |
| DK159491D0 (da) | Behandling af hudsygdomme og tumorer | |
| ES2141787T3 (es) | Derivados de la 1,2,3,4-tetrahidro-9-acridinamina. | |
| IT1222529B (it) | Derivati dell' ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali | |
| AR008244A1 (es) | Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos | |
| ES2013186A6 (es) | Un procedimiento para preparar un derivado de fenilalcanoilamina. | |
| ES2054502T3 (es) | Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion. | |
| ES2128554T3 (es) | Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje. | |
| MX12707A (es) | Procedimiento para la preparacion de nuevos derivados de la oxima del 1, 2, 5, 6-tetrahidropiridin-3-carboxaldehido. | |
| ES2062078T3 (es) | Derivados 4-aminofenol y procedimientos para la preparacion de los mismos. | |
| ES2052901T3 (es) | Un metodo para preparar derivados e isomeros de 4,5,6,7-tetrahidroisotiazolo(4,5-c)piridinas. | |
| ES2122221T3 (es) | Compuestos terapeuticos adecuados para el tratamiento de enfermedades conectadas con la deficiencia de glutation, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2058203T3 (es) | Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos. | |
| ES8506577A1 (es) | Procedimiento para preparar un derivado de ester de cefalosporina | |
| ES8900107A1 (es) | Un procedimiento para preparar derivados de alcanoles heteropoliciclicos | |
| ES2044900T3 (es) | Un proceso para la preparacion de un derivado de antraciclina. | |
| MX9206042A (es) | Nuevos derivados de tiadiazinonas, proceso para su fabricacion y preparado farmaceutico que los contiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20000301 |